Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...

Details for the poster presentation are as follows: Presentation Title: An mRNA-encoded masked IL-12 improves systemic tolerability while maintaining anti-tumor efficacy in preclinical studies Poster ...

Wall Street analysts expect Moderna (MRNA) to post quarterly loss of $2.92 per share in its upcoming report, which indicates a year-over-year increase of 4.9%. Revenues are expected to be $126.98 ...

Nearly a year and a half after Covid vaccines became available to adults in the U.S., the FDA has authorized two vaccines for ...

On Tuesday, the U.S. Department of Health and Human Services announced that the government will invest $176 million in ...

Investors in Moderna Inc (Symbol: MRNA) saw new options begin trading this week, for the May 30th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA ...

Shares of NASDAQ MRNA opened at $24.50 on Wednesday. Moderna has a 52-week low of $23.15 and a 52-week high of $170.47. The business has a fifty day moving average of $31.72 and a two-hundred day ...

If you’re on the fence about investing in Moderna, Inc. or Alvotech because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision. Read on to ...

If you’re on the fence about investing in Vericel Corporation, Moderna or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision.

US stocks skyrocketed higher after President Donald Trump announced that he authorized a 90-day pause on the “reciprocal” tariffs that had gone into effect Wednesday, with the exception of ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Moderna (MRNA – Research Report), with a price target of $32.00. The company’s shares closed yesterday ...

Moderna sued Pfizer and BioNTech for infringing three of Moderna’s patents directed to mRNA and lipid technology. While Pfizer and BioNTech did not file any counterclaims for patent infringement ...